Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Rafina Innovations Inc. (VICA)
USD0.00
+0.00 (+0.00%)
GB OTC Healthcare Medical - Devices
Address
Kintyre House G51 1HJ
Glasgow, GB
Glasgow, GB
CEO
Nikolaos Kardaras
Website
rafina-innovations.com
IPO
2013-10-23
CIK 1402737 ISIN US75063R1068
Description
Rafina Innovations Inc. is a company that develops, researches, commercializes, and markets medical technologies. Its operations are divided into two main areas: its Clinic division and its Technology division. The company manages specialized rehabilitation clinics for prosthetics, orthotics, and comprehensive diabetic foot care, serving patients in Southern Europe, the Middle East, and North Africa. Within its Technology arm, Rafina Innovations Inc. is actively engaged in the creation, development, and market introduction of medical devices, innovative methods, and products. This work covers a broad range of fields, including but not limited to, prosthetics, orthotics, general rehabilitation, bioengineering, mobility, diabetes and diabetic foot care, tissue mechanics, ultrasonics, medical signal processing and analysis, general medical technology, orthopedics, and robotic surgery. Additionally, the company licenses its proprietary technological advancements. Founded in 2007, the company changed its name from HCi Viocare to Rafina Innovations Inc. in July 2018. Its base of operations is in Glasgow, United Kingdom.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.00
+0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
33.8K
Beta
9.70
Float Shares
2.60M
Free Float %
17.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +42.86% | +100.00% | +233.33% | +233.33% | +900.00% | +66.67% | -98.28% | -99.37% | -99.65% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.00
Quality scores
Altman Z-Score
-7.26
Distress
Piotroski F-Score
1 / 9
Weak
MOAT Score
2 / 10
No MOAT
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Devices: +11.2%—
-
EPS growth Medical - Devices: +28.5%-226.5% Q1'22: +99.8% (vs Q1'21)
-
FCF margin FCF growth · Medical - Devices: +30.9%-55.5%
-
EBIT margin Medical - Devices: +6.2%-26.6%
-
ROIC Medical - Devices: +3.3%-19.9% Q1'22: -0.1% (vs Q1'21)
-
Share dilution Medical - Devices: 0.0%+219.8% Q1'22: +152.8% (vs Q1'21)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×-0.39×
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-9.24M
OE per share TTM
-0.08
Owner's Yield
-7,572.80%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
19.1%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-07-20 | Zertalis Constantinos | 10% Owner | P-Purchase | A | Common stock | 3,000 | 1.72 | 5.2K | 87,501 | — | ↗ |
| 2018-07-13 | Zertalis Constantinos | 10% Owner | P-Purchase | A | Common stock | 700 | 1.66 | 1.2K | 84,501 | — | ↗ |
| 2018-06-28 | Zertalis Constantinos | 10% Owner | P-Purchase | A | Common stock | 500 | 0.08 | 40.00 | 1,676,018 | — | ↗ |
| 2018-06-27 | Zertalis Constantinos | 10% Owner | P-Purchase | A | Common stock | 500 | 0.09 | 45.00 | 1,502,155 | — | ↗ |
| 2018-06-25 | Zertalis Constantinos | 10% Owner | P-Purchase | A | Common stock | 1,000 | 0.09 | 90.00 | 1,501,655 | — | ↗ |
| 2018-06-22 | Zertalis Constantinos | 10% Owner | P-Purchase | A | Common stock | 2,000 | 0.10 | 200.00 | 1,352,655 | — | ↗ |
| 2018-06-21 | Zertalis Constantinos | 10% Owner | P-Purchase | A | Common stock | 65,500 | 0.10 | 6.6K | 1,350,655 | — | ↗ |
| 2018-06-20 | Zertalis Constantinos | 10% Owner | P-Purchase | A | Common stock | 3,000 | 0.10 | 297.00 | 1,500,655 | — | ↗ |
| 2018-06-19 | Zertalis Constantinos | 10% Owner | P-Purchase | A | Common stock | 1,000 | 0.10 | 99.00 | 1,282,655 | — | ↗ |
| 2018-06-15 | Zertalis Constantinos | 10% Owner | P-Purchase | A | Common stock | 3,000 | 0.10 | 288.00 | 1,486,655 | — | ↗ |
| 2018-06-12 | Zertalis Constantinos | 10% Owner | P-Purchase | A | Common stock | 1,000 | 0.10 | 100.00 | 1,483,655 | — | ↗ |
| 2018-06-11 | Zertalis Constantinos | 10% Owner | P-Purchase | A | Common stock | 294,840 | 0.05 | 14.7K | 1,281,655 | — | ↗ |
| 2018-06-08 | Zertalis Constantinos | 10% Owner | P-Purchase | A | Common stock | 500 | 0.10 | 50.00 | 985,315 | — | ↗ |
| 2018-06-07 | Zertalis Constantinos | 10% Owner | P-Purchase | A | Common stock | 3,000 | 0.09 | 276.00 | 983,415 | — | ↗ |
| 2018-06-06 | Zertalis Constantinos | 10% Owner | P-Purchase | A | Common stock | 9,000 | 0.10 | 900.00 | 978,915 | — | ↗ |
| 2018-06-01 | Zertalis Constantinos | 10% Owner | P-Purchase | A | Common stock | 600 | 0.07 | 39.00 | 969,915 | — | ↗ |
| 2018-05-30 | Zertalis Constantinos | 10% Owner | P-Purchase | A | Common stock | 1,000 | 0.08 | 75.00 | 966,315 | — | ↗ |
| 2018-05-22 | Zertalis Constantinos | 10% Owner | P-Purchase | A | Common stock | 1,000 | 0.07 | 74.50 | 965,315 | — | ↗ |
| 2018-05-15 | Zertalis Constantinos | 10% Owner | P-Purchase | A | Common stock | 30,000 | 0.07 | 2.2K | 964,315 | — | ↗ |
| 2018-05-14 | Zertalis Constantinos | 10% Owner | P-Purchase | A | Common stock | 1,000 | 0.08 | 75.00 | 933,315 | — | ↗ |
| 2018-05-10 | Zertalis Constantinos | 10% Owner | P-Purchase | A | Common stock | 1,000 | 0.07 | 65.00 | 932,315 | — | ↗ |
| 2018-05-08 | Zertalis Constantinos | 10% Owner | P-Purchase | A | Common stock | 1,000 | 0.08 | 75.00 | 931,315 | — | ↗ |
| 2018-04-24 | Zertalis Constantinos | 10% Owner | P-Purchase | A | Common stock | 20,000 | 0.06 | 1.2K | 930,315 | — | ↗ |
| 2018-04-20 | Zertalis Constantinos | 10% Owner | P-Purchase | A | Common stock | 15,000 | 0.06 | 900.00 | 910,315 | — | ↗ |
| 2018-04-16 | Zertalis Constantinos | 10% Owner | P-Purchase | A | Common stock | 500 | 0.06 | 30.00 | 895,315 | — | ↗ |
| 2018-04-13 | Zertalis Constantinos | 10% Owner | P-Purchase | A | Common stock | 10,000 | 0.06 | 550.00 | 894,815 | — | ↗ |
| 2018-04-12 | Zertalis Constantinos | 10% Owner | P-Purchase | A | Common stock | 315 | 0.05 | 15.75 | 884,815 | — | ↗ |
| 2018-04-05 | Zertalis Constantinos | 10% Owner | P-Purchase | A | Common stock | 500 | 0.07 | 34.50 | 884,000 | — | ↗ |
| 2018-03-30 | Zertalis Constantinos | 10% Owner | — | I | Common stock | 0 | 0.00 | — | 122,710,562 | — | ↗ |
| 2017-12-31 | Leontaritis Sotirios | Director / Officer / 10% Owner | — | D | Common stock | 0 | 0.00 | — | 142,710,562 | — | ↗ |
| 2017-12-31 | Katsaros Sergios | Officer | — | D | Common stock | 0 | 0.00 | — | 1,300,000 | — | ↗ |
| 2017-12-31 | Kardaras Nikolaos | Director / Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2017-12-12 | Katsaros Sergios | Officer | A-Award | A | Stock Option | 10,000,000 | 0.05 | 500.0K | 10,000,000 | — | ↗ |
| 2017-12-11 | Kapatos Christos | Director | A-Award | A | Stock Option | 25,000,000 | 0.05 | 1.25M | 25,000,000 | — | ↗ |
| 2017-03-01 | Katsaros Sergios | Officer | J-Other | D | Stock award | 100,000 | 0.00 | — | 0 | — | ↗ |
| 2017-01-01 | Leontaritis Sotirios | Director / Officer / 10% Owner | A-Award | A | Stock Option | 3,000,000 | 0.30 | 900.0K | 3,000,000 | — | ↗ |
| 2016-10-04 | Katsaros Sergios | Officer | A-Award | A | Common Stock | 100,000 | 0.85 | 84.5K | 200,000 | — | ↗ |
| 2016-09-01 | Katsaros Sergios | Officer | J-Other | D | Stock Award | 100,000 | 0.00 | — | 100,000 | — | ↗ |
| 2016-03-01 | Katsaros Sergios | Officer | A-Award | A | Stock Award | 200,000 | 0.00 | — | 200,000 | — | ↗ |
| 2015-12-31 | Leontaritis Sotirios | Director / Officer / 10% Owner | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2015-12-31 | Kist Heleen Francoise | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2015-09-09 | Katsaros Sergios | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2015-06-02 | Kardaras Nikolaos | Director / Officer | A-Award | A | Common shares | 100,000 | 4.50 | 450.0K | 100,000 | — | ↗ |
| 2015-05-28 | Leontaritis Sotirios | Director / Officer / 10% Owner | J-Other | A | Common shares | 11,291,033 | 0.03 | 338.7K | 20,524,366 | — | ↗ |
| 2015-05-11 | Kapatos Christos | Director | A-Award | A | Common shares | 1,000,000 | 4.55 | 4.55M | 2,000,000 | — | ↗ |
| 2014-12-24 | Leontaritis Sotirios | Director / Officer / 10% Owner | P-Purchase | A | Common stock | 133,333 | 1.50 | 200.0K | 9,233,333 | — | ↗ |
| 2014-12-09 | Leontaritis Sotirios | Director / Officer / 10% Owner | A-Award | A | Common shares | 9,000,000 | 0.03 | 299.7K | 9,100,000 | — | ↗ |
| 2014-11-07 | Kist Heleen Francoise | Officer | — | D | Common stock | 0 | 0.00 | — | 100,000 | — | ↗ |
| 2014-10-08 | Leontaritis Sotirios | Director / Officer / 10% Owner | G-Gift | D | Common stock | 500,000 | 0.00 | — | 2,175,440 | — | ↗ |
| 2014-05-02 | Leontaritis Sotirios | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 200,000 | 1.00 | 200.0K | 2,675,440 | — | ↗ |
| 2014-05-01 | Leontaritis Sotirios | Director / Officer / 10% Owner | S-Sale | D | Common stock | 200,000 | 1.00 | 200.0K | 2,875,440 | — | ↗ |
| 2014-04-17 | Kapatos Christos | Director | A-Award | A | Common shares | 500,000 | 2.25 | 1.13M | 1,000,000 | — | ↗ |
| 2014-04-16 | Leontaritis Sotirios | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 7,410 | 1.00 | 7.4K | 3,430,440 | — | ↗ |
| 2014-04-03 | Leontaritis Sotirios | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 200,000 | 1.00 | 200.0K | 3,800,000 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-217.1K
Shares Outstanding
14.57M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Paraskevi Pilarinou | Financial Controller | 115.8K | female |
| Georgios Thrapsaniotis | Treasurer & Director | — | male |
| Hari Elangovan | Acting Chief Technology Officer | — | — |
| Evaggelia Moschidou | Marketing Director | — | female |
| Paraskevi Pylarinou | Chief Financial Officer, Secretary & Director | — | female |
| Yiannis Levantis | Independent Technology Advisor & Director | — | male |
| Nikolaos Kardaras | Head of Legal Department | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for VICA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
